A Phase 2, Randomized, Double-blind, Parallel, Placebo-controlled, Multi-center Study to Compare Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

Trial Profile

A Phase 2, Randomized, Double-blind, Parallel, Placebo-controlled, Multi-center Study to Compare Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2013

At a glance

  • Drugs Eperisone (Primary)
  • Indications Back pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2013 New source identified and integrated (Korean Clinical Trials Register; KCT0000925).
    • 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top